title: Bosentan may induce arthritis flare in patients with scleroderma concomitantly treated with methotrexate.
authors.forename: F
authors.initials: F
authors.lastname: Cozzi
authors.forename: P A
authors.initials: PA
authors.lastname: Ostuni
authors.forename: H
authors.initials: H
authors.lastname: Marotta
authors.forename: P
authors.initials: P
authors.lastname: Sfriso
authors.forename: M
authors.initials: M
authors.lastname: Favaro
authors.forename: S
authors.initials: S
authors.lastname: Todesco
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects*; D001168:Arthritis / Q000139:chemically induced*; D000077300:Bosentan; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan; D008727:Methotrexate